利用器官芯片模型研究宿主微生物群动力学和针对性治疗炎症性肠病的目标疗法
Tim Kaden1,2, Raquel Alonso-Román3,4,5, Johannes Stallhofer6
1Dynamic42 GmbH, 07745, Jena, Germany.
Advanced healthcare materials
|November 4, 2024
概括
人体肠道器官芯片模型为研究炎症性肠病 (IBD) 病原和宿主微生物群相互作用提供了一种新的方法. 这些先进的模型可以改善针对IBD的向疗法和个性化药物的开发.
科学领域:
- 胃肠病学 胃肠病学
- 翻译医学是一种翻译医学.
- 微生物学 微生物学
背景情况:
- 全球炎症性肠病 (IBD) 发病率正在上升,由于其复杂,多因素的病因,这给研究带来了重大挑战.
- 目前的体外模型,如二维细胞培养和动物模型,在准确复制人类肠道微环境和宿主微生物群相互作用方面存在局限性.
- 由于动物模型的固有差异和传统培养不能维持微生物群落,弥合IBD研究结果和临床实践之间的差距仍然很困难.
研究的目的:
- 阐明IBD的易感性和生物特征,特别关注肠道粘膜屏障中的宿主微生物群相互作用.
- 探索人类肠道器官芯片 (OoC) 模型作为IBD研究先进的体外系统的潜力.
- 讨论OOC模型在确定IBD的疾病驱动因素,治疗目标和个性化药物策略中的应用.
主要方法:
- 审查和综合有关IBD病原体,常规模型和新兴器官芯片技术的现有文献.
- 在IBD中肠道粘膜屏障的背景下,对宿主微生物群相互作用的阐释.
- 讨论人类肠道器官芯片模型对肠道微环境及其与IBD相关性的概述能力.
主要成果:
- 器官芯片模型准确地复制了人类肠道的微环境,包括复杂的宿主微生物群相互作用,超越了二维培养的局限性.
- 这些模型在研究IBD病原体方面具有优势,因为它们能够模拟各种复杂性并促进疾病驱动因素的识别.
- 器官芯片技术在评估与微生物群相关的疗法和推进IBD治疗的个性化医学方法方面表现有前途.
结论:
- 人体肠道器官芯片模型代表了比研究IBD的传统方法的重大进步.
- OoC模型为了解IBD病原和开发新型治疗干预提供了更具预测性的平台.
- 器官芯片技术的应用对个性化医疗策略在管理炎症性肠道疾病方面具有相当大的潜力.
相关概念视频
01:24iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...